One of the ways technology is really helping society when it comes to the medical field is trying to find a way to solve some of our worst diseases and conditions. To that end, the National Institute of Health Center for Regenerative Medicine (NIH-CRM) has awarded a new $7-million contract to Cellular Dynamics.
Cellular Dynamics is one of the world’s largest producers in the commercial market, of human induced pluripotent stem cell (iPS) lines and tissue cells. The contract has a three-year life and could actually total less than the $7 million if the company is unable to meet all the criteria detailed in the agreement.
Consumer Dynamics will have to produce a set number of iPS cell lines in order to honor the contract. The company says it has already started its work and has delivered on several of the required cell lines already.
The contract is a way for the NIH-CRM to help researchers working in this field to move the practice of stem cell research forward. Most of these cells will reportedly be used mostly for preclinical research.
Cellular Dynamics is one of the only companies in the world capable of providing these particular iPS cell lines.
"This contract enables NIH researchers to easily access our human iPS cell-derived cells and accelerate the pace of their research," said Chris Parker, chief commercial officer at CDI. "Scientists can now concentrate on their experiments and the data they generate instead of trying to manufacture a consistent and pure supply of human cells. Our expertise is providing the necessary tools – human cells – so that researchers can focus on discoveries."
With the numerous controversies surrounding stem cell research, individual companies and research facilities alike are looking for ways to conduct this kind of research by means that won’t come under as much fire from the general public.